Skip to main content
Springer logoLink to Springer
. 2020 Feb 28;80(4):447. doi: 10.1007/s40265-020-01280-5

Correction to: Pexidartinib: First Approval

Yvette N Lamb 1,
PMCID: PMC7058556  PMID: 32112350

Correction to: Drugs (2019) 79:1805–1812 10.1007/s40265-019-01210-0

The article Pexidartinib: First Approval, written by Yvette N. Lamb was originally published Online First without Open Access. After publication online Daiichi Sankyo, Inc., requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by Daiichi Sankyo, Inc. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit original author(s) and the source, provide a link to the Creative Commons licence and indicate if changes were made.

The original article has been corrected.


Articles from Drugs are provided here courtesy of Springer

RESOURCES